Latest filing published 07 Mar 2024 for Idexx Laboratories INC /de, €92k.
Filing timeline
BuySaleInsider track record
James F. Polewaczyk: trading record in brief
This profile gathers the share dealings of James F. Polewaczyk in Idexx Laboratories INC /de, where the filings describe the role as chief executive. The record holds 111 filings, for trades running from 14 February 2008 to 6 March 2024.
The open-market record consists of 28 sales worth €33.6M, with no purchase. Other entries cover 11 share grants and 71 option exercises. 2024 to date brings no purchases and 3 sales.
The latest filing, published on 7 March 2024, reports an option exercise of €92k in Idexx Laboratories INC /de. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to James F. Polewaczyk
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 483 shares@ US$206.940.2% of flowCommon StockSEC:0000874716-24-000065:1
- 2,226 shares@ US$288.781.4% of flowCommon StockSEC:0000874716-24-000065:2
- 4,640 shares@ US$544.085.4% of flowCommon StockSEC:0000874716-24-000065:3
- 4,134 shares@ US$557.945.0% of flowCommon StockSEC:0000874716-24-000065:4
- 3,290 shares@ US$558.884.0% of flowCommon StockSEC:0000874716-24-000065:5
- 680 shares@ US$559.330.8% of flowCommon StockSEC:0000874716-24-000065:6
- 755 shares@ US$206.943.3% of flowCommon StockSEC:0000874716-24-000065:0
- 216 shares0Common StockSEC:0000874716-24-000041:1
- 161 shares0Common StockSEC:0000874716-24-000041:2
- 204 shares0Common StockSEC:0000874716-24-000041:3
- 220 shares0Common StockSEC:0000874716-24-000041:4
- 279 shares@ US$560.560.3% of flowCommon StockSEC:0000874716-24-000041:5
- 126 shares0Common StockSEC:0000874716-24-000041:0
- 6,680 shares@ US$288.784.2% of flowCommon StockSEC:0000874716-23-000145:1
- 3,116 shares@ US$520.193.5% of flowCommon StockSEC:0000874716-23-000145:2
- 3,378 shares@ US$521.003.8% of flowCommon StockSEC:0000874716-23-000145:3
- 1,202 shares@ US$522.311.4% of flowCommon StockSEC:0000874716-23-000145:4
- 3,940 shares@ US$523.564.5% of flowCommon StockSEC:0000874716-23-000145:5
- 4,956 shares@ US$206.9421.7% of flowCommon StockSEC:0000874716-23-000145:0
- 706 shares@ US$141.600.2% of flowCommon StockSEC:0000874716-23-000113:1
- 7,151 shares@ US$141.602.2% of flowCommon StockSEC:0000874716-23-000113:2
- 560 shares@ US$178.260.2% of flowCommon StockSEC:0000874716-23-000113:3
- 5,865 shares@ US$178.262.2% of flowCommon StockSEC:0000874716-23-000113:4
- 500 shares@ US$508.960.5% of flowCommon StockSEC:0000874716-23-000113:5
- 3,318 shares@ US$510.473.6% of flowCommon StockSEC:0000874716-23-000113:8
25 of 111 declarations
